"Bylo zji\u0161t\u011Bno, \u017Ee Sandostatin sni\u017Euje vst\u0159eb\u00E1v\u00E1n\u00ED cyklosporinu z tr\u00E1vic\u00ED trubice a zpomaluje vst\u0159eb\u00E1v\u00E1n\u00ED cimetidinu. \nSou\u010Dasn\u00E9 pod\u00E1v\u00E1n\u00ED oktreotidu a bromokriptinu zvy\u0161uje biologickou dostupnost bromokriptinu. \nOmezen\u00E9 mno\u017Estv\u00ED publikovan\u00FDch dat nazna\u010Duje, \u017Ee analoga somatostatinu mohou sni\u017Eovat metabolickou clearance l\u00E1tek metabolizovan\u00FDch enzymy cytochromu P450, co\u017E m\u016F\u017Ee b\u00FDt n\u00E1sledek supresi r\u016Fstov\u00E9ho hormonu. Proto\u017Ee nen\u00ED mo\u017En\u00E9 vylou\u010Dit, \u017Ee oktreotid m\u016F\u017Ee m\u00EDt tento \u00FA\u010Dinek, mus\u00ED b\u00FDt l\u00E1tky s\u00A0n\u00EDzk\u00FDm terapeutick\u00FDm indexem metabolizovan\u00E9 CYP3A4, u\u017E\u00EDv\u00E1ny opatrn\u011B (nap\u0159. chinidin, terfenadin). \n \n"@cs . . . "4.5\tInterakce s\u00A0jin\u00FDmi l\u00E9\u010Div\u00FDmi p\u0159\u00EDpravky a jin\u00E9 formy interakce "@cs . . . "004.005" . .